Immunotherapies | Australian Biotech Company News

Home Tags Immunotherapies

Biotechnology

Astellas Acquires Xyphos for Up to $665M, Boosting Cancer Immunotherapy Pipeline

BioChannel - December 27, 2019

Biotechnology

Merck & Co., Sanofi Shell Out $5.2B in Deals to Strengthen...

BioChannel - December 9, 2019

Biotechnology

Tocagen Axing 65% of Staff after Cancer Immunotherapy Combination Fails Phase...

BioChannel - October 4, 2019

Biotechnology

Breathalyzer Sniffs Out Potential Cancer Immunotherapy Responders

BioChannel - September 18, 2019

Biotechnology

Breakthroughs in Immunotherapy

BioChannel - September 12, 2019

Biotechnology

Celgene, Immatics Launch Up-to-$1.5B+ Cancer T-Cell Collaboration

BioChannel - August 28, 2019

Biotechnology

Microbiomes of Lab Mice Take a Walk on the Wild Side

BioChannel - August 2, 2019

Biotechnology

Celgene Scraps $2.6B Deal, Licenses Jounce Antibody in Restructured Cancer Collaboration

BioChannel - July 24, 2019

Biotechnology

Q&A: Evolution of CAR-T Cell Therapy and Future Directions

BioChannel - July 5, 2019

Biotechnology

Polyfunctional Strength Offers a New Approach to Defining Quality in Cell...

BioChannel - May 31, 2019

12 Page 1 of 2

Stay connected

Recent posts

Biotechnology – The New York Times

BioChannel - January 18, 2020

[Trends 2020] These Factors Will Shape the Biotechnology Industry – Entrepreneur

BioChannel - January 18, 2020

DNA Data Storage Project Receives €20.7M from US Intelligence Agency

BioChannel - January 18, 2020

Random article

Biotechnology – The New York Times

[Trends 2020] These Factors Will Shape the Biotechnology Industry – Entrepreneur

DNA Data Storage Project Receives €20.7M from US Intelligence Agency

International Collaboration on Brink of Resurrecting Northern White Rhinos